178 related articles for article (PubMed ID: 20305672)
1. Is interleukin-6 receptor blockade the Holy Grail for inflammatory diseases?
Febbraio MA; Rose-John S; Pedersen BK
Clin Pharmacol Ther; 2010 Apr; 87(4):396-8. PubMed ID: 20305672
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders.
Paul-Pletzer K
Drugs Today (Barc); 2006 Sep; 42(9):559-76. PubMed ID: 17028666
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.
Patel AM; Moreland LW
Drug Des Devel Ther; 2010 Oct; 4():263-78. PubMed ID: 21116333
[TBL] [Abstract][Full Text] [Related]
4. Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?
Moots RJ; Ostör AJ; Isaacs JD
Expert Opin Investig Drugs; 2009 Nov; 18(11):1687-99. PubMed ID: 19715449
[TBL] [Abstract][Full Text] [Related]
5. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.
Lazzerini PE; Capecchi PL; Guidelli GM; Selvi E; Acampa M; Laghi-Pasini F
Drug Des Devel Ther; 2016; 10():3083-3098. PubMed ID: 27713619
[TBL] [Abstract][Full Text] [Related]
6. The clinical efficacy of tocilizumab in rheumatoid arthritis.
Mircic M; Kavanaugh A
Drugs Today (Barc); 2009 Mar; 45(3):189-97. PubMed ID: 19436841
[TBL] [Abstract][Full Text] [Related]
7. Humanized antihuman IL-6 receptor antibody, tocilizumab.
Nishimoto N; Kishimoto T
Handb Exp Pharmacol; 2008; (181):151-60. PubMed ID: 18071945
[TBL] [Abstract][Full Text] [Related]
8. The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.
Murakami M; Nishimoto N
Curr Opin Rheumatol; 2011 May; 23(3):273-7. PubMed ID: 21427577
[TBL] [Abstract][Full Text] [Related]
9. Targeting IL-6 in the treatment of inflammatory and autoimmune diseases.
Ding C; Cicuttini F; Li J; Jones G
Expert Opin Investig Drugs; 2009 Oct; 18(10):1457-66. PubMed ID: 19715447
[TBL] [Abstract][Full Text] [Related]
10. Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?
Johnson J; Wang MY
Neurosurgery; 2008 Aug; 63(2):N8. PubMed ID: 18797345
[No Abstract] [Full Text] [Related]
11. [Humanized anti-human IL-6 receptor antibody, tocilizumab].
Nishimoto N
Nihon Rinsho; 2007 Jul; 65(7):1218-25. PubMed ID: 17642235
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of blocking IL-6 receptor.
Mima T; Nishimoto N
Curr Opin Rheumatol; 2009 May; 21(3):224-30. PubMed ID: 19365268
[TBL] [Abstract][Full Text] [Related]
13. Drug eruption induced by IL-6 receptor inhibitor tocilizumab.
Yoshiki R; Nakamura M; Tokura Y
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):495-6. PubMed ID: 19754658
[No Abstract] [Full Text] [Related]
14. Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.
Kavanaugh A
Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S16-20. PubMed ID: 17708740
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 in the pathogenesis of rheumatoid arthritis.
Park JY; Pillinger MH
Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S4-10. PubMed ID: 17708744
[TBL] [Abstract][Full Text] [Related]
16. [Clinical benefits of anti-human IL-6 receptor antibody therapy].
Nishimoto N
Clin Calcium; 2007 Apr; 17(4):562-8. PubMed ID: 17404486
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab.
Venkiteshwaran A
MAbs; 2009; 1(5):432-8. PubMed ID: 20065633
[TBL] [Abstract][Full Text] [Related]
18. [Tocilizumab in rheumatoid arthritis. Interleukin 6 as a new target].
Heinzl S
Med Monatsschr Pharm; 2008 Dec; 31(12):450-3. PubMed ID: 19133593
[No Abstract] [Full Text] [Related]
19. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
Tanaka T; Narazaki M; Ogata A; Kishimoto T
Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 blockade-associated weight gain with abdominal enlargement in a patient with rheumatoid arthritis.
Younis S; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M; Slobodin G
J Clin Rheumatol; 2013 Jan; 19(1):48-9. PubMed ID: 23319026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
